Overview

Two Studies to Determine if Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of the Skin.

Status:
Terminated
Trial end date:
2004-03-01
Target enrollment:
Participant gender:
Summary
The purpose of the two studies is to determine whether an experimental therapy using a photoactive drug, verteporfin, in combination with direct light exposure of basal cell carcinoma of the skin can safely eliminate these skin tumors.
Phase:
Phase 3
Details
Lead Sponsor:
QLT Inc.
Collaborator:
Novartis
Treatments:
Verteporfin